Skip to main content

Part of the book series: Current Molecular Medicine ((CMM,volume 1))

  • 91 Accesses

Abstract

The (idiopathic) inflammatory myopathies are a heterogenous group of diseases, including dermatomyositis (DM), different forms of polymyositis (PM), and inclusionbody myositis (IBM) (reviewed in refs. 1–4). Clinically, DM is distinguished from PM and IBM by characteristic skin manifestations. A microscopic feature highly characteristic of DM is perifascicular atrophy, which is due to degeneration of muscle fibers at the periphery of muscle fascicles secondary to microvascular damage. Quantitative morphological analyses suggest that depletion of capillaries is one of the earliest changes in DM. Immunofluorescence studies revealed the deposition of complement in or around microvascular endothelium in a significant proportion of capillaries (5). These observations support the concept that an antibody- or immune-complex-mediated response against a vascular—endothelial component is a primary pathogenetic mechanism in DM.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hohlfeld, R. and Engel, A. G. (1994) The immunobiology of muscle. Immunol. Today 15, 269–274.

    Article  PubMed  CAS  Google Scholar 

  2. Engel, A. G., Hohlfeld, R., and Banker, B. Q. (1994) The polymyositis and dermatomyositis syndromes, in Myology (Engel, A. G. and Franzini-Armstrong, C., eds.), McGraw-Hill, New York, pp. 1335–1383.

    Google Scholar 

  3. Dalakas, M. C. and Sivakumar, K. (1996) The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis. Curr. Opin. Neurol. 9, 235–239.

    Article  PubMed  CAS  Google Scholar 

  4. Mantegazza, R., Bernasconi, P., Confalioneri, P., and Cornelio, D. (1997) Inflammatory myopathies and systematic disorders: a review of immunopathogenic mechanisms and clinical features. J. Neurol. 244, 277–287.

    Article  PubMed  CAS  Google Scholar 

  5. Mendell, J. R., Garcha, T. S., and Kissel, J. T. (1996) The immunopathogenic role of complement in human muscle disease. Curr. Opin. Neurol. 9, 226–234.

    Article  PubMed  CAS  Google Scholar 

  6. Arahata, K. and Engel, A. G. (1986) Monoclonal antibody analysis of mononuclear cells in myopathies III. Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann. Neurol. 19, 112–125.

    Article  PubMed  CAS  Google Scholar 

  7. Hohlfeld, R. and Engel, A. G. (1991) Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies. Ann. Neurol. 29, 498–507.

    Article  PubMed  CAS  Google Scholar 

  8. Hohlfeld, R., Engel, A. G., Ii, K., and Harper, M. C. (1991) Polymyositis mediated by T lymphocytes that express the γ/δ receptor. N. Engl. J. Med. 324, 877–881.

    Article  PubMed  CAS  Google Scholar 

  9. Dalakas, M. C. (1995) Immunopathogenesis of inflammatory myopathies. Ann. Neurol. 37, S74—S86.

    PubMed  Google Scholar 

  10. Griggs, R. C., Askanas, V., DiMauro, S., Engel, A. G., Karpati, G., Mendell, J. R., et al. (1995) Inclusion body myositis and myopathies. Ann. Neurol. 38, 707–713.

    Article  Google Scholar 

  11. Askanas, V. (1997) New developments in heredity inclusion body myopathies. Ann. Neurol. 41, 421–422.

    Article  PubMed  CAS  Google Scholar 

  12. Askanas, V., Engel, W. K., and Mirabella, M. (1994) Idiopathic inflammatory myopathies. Inclusion-body myositis, polymyositis, and dermatomyositis. Curr. Opin. Neurol. 7, 48–456.

    Article  Google Scholar 

  13. Lundberg, I., Brengman, J. M., and Engel, A. G. (1995) Analysis of cytokine expression in muscle in inflammatory myopathies. Duchenne dystrophy and non-weak controls. J. Neuroimmunol. 63, 9–16.

    Article  PubMed  CAS  Google Scholar 

  14. Confalonieri, P., Bernasconi, P., Cornelio, F., and Mantegazza, R. (1997) Transforming growth factor-β1 in polymyositis and dermatomyositis correlates with fibrosis but not with cell infiltrate. J. Neuropathol. Exp. Neurol. 56, 479–484.

    Article  PubMed  CAS  Google Scholar 

  15. Lundberg, I., Ulfgren, A.-K., Nyberg, P., Andersson, U., and Klareskog, L. (1997) Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 40, 865–874.

    Article  PubMed  CAS  Google Scholar 

  16. Tews, D. S. and Goebel, H. H. (1996) Cytokine expression profile in idiopathic inflammatory myopathies. J. Neuropathol. Exp. Neurol. 55, 342–347.

    Article  PubMed  CAS  Google Scholar 

  17. Tateyama, M., Nagano, I., Yoshioka, M., Chida, K., Nakamura, S., and Itoyama, Y. (1997) Expression of tumor necrosis factor-a in muscles of polymyositis. J. Neurol. Sci. 146, 45–51.

    Article  PubMed  CAS  Google Scholar 

  18. De Bleecker, J. L. and Engel, A. G. (1994) Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy. J. Neuropathol. Exp. Neurol. 53, 369–376.

    Article  PubMed  Google Scholar 

  19. Bartoccioni, E., Gallucci, S., Scuderi, F., Ricci, E., Servidei, S., Broccolini, A., et al. (1994) MHC class I, MHC class II and intercellular adhesion molecule-1 expression in inflammatory myopathies. Clin. Exp. Immunol. 95, 166–172.

    Article  PubMed  CAS  Google Scholar 

  20. Tews, D. S. and Goebel, H. H. (1995) Expression of cell adhesion molecules in inflammatory myopathies. J. Neuroimmunol. 59, 185–194.

    Article  PubMed  CAS  Google Scholar 

  21. Cid, M.-C., Grau, J.-M., Casademont, J., Tobías, E., Picazo, A., Coll-Vinent, B., et al. (1996) Leucocyte/endothelial cells adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies. Clin. Exp. Immunol. 104, 476–473.

    Google Scholar 

  22. Gallucci, S., Provenzano, C., Mazzarelli, P., Scuderi, F., and Bartoccioni, E. (1998) Myoblasts produce IL-6 in response to inflammatory stimuli. Int. Immunol. 10, 267–273.

    Article  PubMed  CAS  Google Scholar 

  23. Engel, A. G. and Arahata, K. (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. II Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann. Neurol. 16, 209–216.

    Article  PubMed  CAS  Google Scholar 

  24. De Bleecker, J. L. and Engel, A. G. (1995) Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies. Am. J. Pathol. 146, 1178–1187.

    PubMed  Google Scholar 

  25. Iannone, F., Cauli, A., Yanni, G., Kingsley, G., Isenberg, D. A., Corrigall, V. M., et al. (1996) T lymphocyte immunophenotyping in polymyositis and dermatomyositis. Br. J. Rheumatol. 35, 839–845.

    Article  PubMed  CAS  Google Scholar 

  26. Bender, A., Ernst, N., Iglesias, A., Dornmair, K., Wekerle, H., and Hohlfeld, R. (1995) T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8 T cells. J. Exp. Med. 181, 1863–1868.

    Article  PubMed  CAS  Google Scholar 

  27. Mantegazza, R., Andreetta, F., Bernasconi, P., Baggi, F., Oksenberg, J. R., Simoncini, O., et al. (1993) Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. J. Clin. Invest. 91, 2880–2886.

    Article  PubMed  CAS  Google Scholar 

  28. O’ Hanlon, T. P., Dalakas, M. C., Plotz, P. H., and Miller, F. W. (1994) Predominant TCR-αβ variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. J. Immunol. 152, 2569–2576.

    Google Scholar 

  29. Lindberg, C., Oldfors, A., and Tarkowski, A. (1994) Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies. Eur. J. Immunol. 24, 2659–2663.

    Article  PubMed  CAS  Google Scholar 

  30. Pluschke, G., Rüegg, D., Hohlfeld, R., and Engel, A. G. (1992) Autoaggressive myocytotoxic T lymphocytes expressing an unusual γ/δ T cell receptor. J. Exp. Med. 176, 1785–1789.

    Article  PubMed  CAS  Google Scholar 

  31. Hohlfeld, R. and Engel, A. G. (1992) Expression of 65-kd heat shock proteins in the inflammatory myopathies. Ann. Neurol. 32, 821–823.

    Article  PubMed  CAS  Google Scholar 

  32. O’ Hanlon, T. P., Dalakas, M. C., Plotz, P. H., and Miller, F. W. (1994) The αβ T-cell receptor repertoire in inclusion body myositis: diverse patterns of gene expression by muscle-infiltrating lymphocytes. J. Autoimmun. 7, 321–333.

    Article  Google Scholar 

  33. Fyhr, I.-M., Moslemi, A.-R., Tarkowski, A., Lindberg, C., and Oldfors, A. (1996) Limited T cell receptor V gene usage in inclusion body myositis. Scand. J. Immunol. 43, 109–114.

    Article  PubMed  CAS  Google Scholar 

  34. Fleischer, B. (1995) Superantigens. Acta Pathol. Microbiol. Immunol. Scand. (C) 102, 3–12.

    Google Scholar 

  35. Kotzin, B. L., Leung, D. Y. M., Kappler, J., and Marrack, P. (1995) Superantigens and their potential role in human disease. Adv. Immunol. 54, 99–166.

    Article  Google Scholar 

  36. Karpati, G., Pouliot, Y., and Carpenter, S. (1988) Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann. Neurol. 23, 64–72.

    Article  PubMed  CAS  Google Scholar 

  37. Emslie-Smith, A. M., Arahata, K., and Engel, A. G. (1989) Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum. Pathol. 20, 224–231.

    Article  PubMed  CAS  Google Scholar 

  38. Bender, A., Behrens, L., Engel, A. G., and Hohlfeld, R. (1998) T-cell heterogeneity in muscle lesions of inclusion body myositis. J. Neuroimmunol. 84, 86–91.

    Article  PubMed  CAS  Google Scholar 

  39. Mikol, J. and Engel, A. G. (1994) Inclusion body myositis, in Myology. Basic and Clinical. (Engel, A. G. and Franzini-Armstrong, C., eds.), McGraw-Hill, New York, pp. 1384–1398.

    Google Scholar 

  40. Carpenter, S. (1996) Inclusion body myositis. J. Neuropathol. Exp. Neurol. 55, 1105–1114.

    Article  PubMed  CAS  Google Scholar 

  41. Pruitt, J. N., Showalter, C. J., and Engel, A. G. (1996) Sporadic inclusion body myositis: counts of different types of abnormal fibers. Ann. Neurol. 39, 139–143.

    Article  PubMed  Google Scholar 

  42. Garlepp, M. J., Laing, B., Zilko, P. J., Ollier, W., and Mastaglia, F. L. (1994) HLA associations with inclusion body myositis. Clin. Exp. Immunol. 98, 40–45.

    Article  PubMed  CAS  Google Scholar 

  43. Garlepp, M. J. and Mastaglia, F. L. (1996) Inclusion body myositis. J. Neurol. Neurosurg. Psychiatr. 60, 251–255.

    Article  PubMed  CAS  Google Scholar 

  44. Orimo, S., Koga, R., Nakamura, K., Arai, M., Tamaki, M., Sugita, H., et al. (1994) Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies. Neuromusc. Disord. 4, 219–226.

    Article  PubMed  CAS  Google Scholar 

  45. Goebels, N., Michaelis, D., Engelhardt, M., Huber, S., Bender, A., Pongratz, D., et al. (1996) Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J. Clin. Invest. 97, 2905–2910.

    Article  PubMed  CAS  Google Scholar 

  46. Cherin, P., Herson, S., Crevon, M. C., Hauw, J.-J., Cervera, P., Galanaud, P., et al. (1996) Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-b genes and the protein TIA-I in muscle biopsies of myositis. J. Rheumatol. 23, 1135–1142.

    PubMed  CAS  Google Scholar 

  47. Liu, C.-C., Walsh, C. M., and Young, J. D. E. (1995) Perforin: Structure and Function. Immunol. Today 16, 194–201.

    Article  PubMed  Google Scholar 

  48. Henkart, P. A. (1994) Two pathways and multiple effector molecules. Immunity 1, 343–346.

    Article  PubMed  CAS  Google Scholar 

  49. Behrens, L., Bender, A., Johnson, M. A., and Hohlfeld, R. (1997) Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bc1–2 in muscle fibers and inflammatory cells. Brain 120, 929–938.

    Article  PubMed  Google Scholar 

  50. Schneider, C., Gold, R., Dalakas, M. C., Schmied, M., Lassmann, H., Toyka, K. V., et al. (1996) MHC class I mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory CT cells: studies in patients with inclusion body myositis. J. Neuropathol. Exp. Neural. 55, 1205–1209.

    Article  CAS  Google Scholar 

  51. Inukai, A., Kobayashi, Y., Ito, K., Doyu, M., Takano, A., Honda, H., et al. (1997) Expression of Fas antigen is not associated with apoptosis in human myopathies. Muscle Nerve 20, 702–709.

    Article  PubMed  CAS  Google Scholar 

  52. Tews, D. S. and Goebel, H. H. (1997) Apoptosis-related proteins in skeletal muscle fibers of spinal muscular atrophy. J. Neuropathol. Exp. Neural. 56, 150–156.

    Article  CAS  Google Scholar 

  53. Lee, R. K., Spielman, J., and Podack, E. R. (1996) bcl-2 protects against Fas-based but not perforin-based T cell-mediated cytolysis. Int. Immunol. 8, 991–1000.

    Article  PubMed  CAS  Google Scholar 

  54. Farrow, S. N. and Brown, R. (1996) New members of the Bc1–2 Family and their protein partners. Curr. Opin. Genet. Dev. 6, 45–49.

    Article  PubMed  CAS  Google Scholar 

  55. Lynch, D. H., Ramsdell, F., and Alderson, M. R. (1995) Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16, 569–574.

    Article  PubMed  CAS  Google Scholar 

  56. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., et al. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441–444.

    Article  PubMed  CAS  Google Scholar 

  57. Goebels, N., Michaelis, D., Wekerle, H., and Hohlfeld, R. (1992) Human myoblasts as antigen presenting cells. J. Immunol. 149, 661–667.

    PubMed  CAS  Google Scholar 

  58. Hohlfeld, R. and Engel, A. G. (1990) Induction of HLA-DR expression on human myoblasts with interferon-gamma. Am. J. Pathol. 136, 503–508.

    PubMed  CAS  Google Scholar 

  59. Mantegazza, R., Hughes, S. M., Mitchell, D., Travis, M., Blau, H. M., and Steinman, L. (1991) Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-y. Neurology 41, 1 128–1132.

    Article  Google Scholar 

  60. Hohlfeld, R. and Engel, A. G. (1990) Lysis of myotubes by alloreactive cytotoxic T cells and natural killer cells. Relevance to myoblast transplantation. J. Clin. Invest. 86, 370–374.

    Article  PubMed  CAS  Google Scholar 

  61. Lindberg, C., Oldfors, A., and Tarkowski, A. (1995) Local T-cell proliferation and differentiation in inflammatory myopathies. Scand. J. Immunol. 41, 421–426.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Goebels, N., Hohlfeld, R. (2000). Inflammatory Myopathies. In: Tsokos, G.C. (eds) Principles of Molecular Rheumatology. Current Molecular Medicine, vol 1. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-018-6_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-018-6_22

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-182-0

  • Online ISBN: 978-1-59259-018-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics